Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

menswear

Goldlion menswear

Goldlion joins stock retreat as brand loses its luster

The menswear maker has become the latest firm to announce plans to delist from the Hong Kong market as it grapples with weak Chinese consumption Key Takeaways: The privatization is…
December 27, 2024
0533.HK

NEWS BRIEF: China Lilang’s revenue rises 7.3% in tough retail environment

Menswear and accessories manufacturer China Lilang Ltd.’s (1234.HK) reported its revenue rose 7.3% in the six months to June to 1.6 billion yuan ($223 million), as it outperformed a challenging…
August 13, 2024
1234.HK

Recent Articles

Goldlion menswear
December 27, 2024

Goldlion joins stock retreat as brand loses its luster

0533.HK
August 13, 2024

NEWS BRIEF: China Lilang’s revenue rises 7.3% in tough retail environment

1234.HK

RELATED ARTICLES

  1. Hengrui Pharma
    December 19, 2024
    Hengrui Pharma accelerates bid for global brand status
    600276.SHG
  2. January 14, 2025
    Shein loses its shine on bumpy path to London listing
  3. February 24, 2025
    AAC Technologies scores big turnaround. But is its stock running out of steam?
    2018.HK
  4. February 6, 2025
    After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
    2696.HK
  5. February 26, 2025
    Last orders: leading rice noodle chain to delist from Hong Kong 
    2217.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.